Cannabis
Kiaro Signs Distribution Agreement with Pineapple Express
Saskatoon residents can now order cannabis to their doorstep within two hours of online purchase, thanks to a new partnership between Vancouver-based cannabis brand Kiaro and Pineapple Express Delivery.
The distribution agreement enables Kiaro to provide expedited delivery of cannabis products throughout Saskatoonwithin two hours or less, supporting the brand’s ongoing commitment to provide a customer forward service that surpasses expectations and adds significant value beyond the transaction. The agreement also improves accessibility of legal cannabis products, thereby supporting the disruption of the unregulated market, as outlined in the Cannabis Act.
Kiaro offers a diverse product portfolio appealing to the cannabis curious as well as seasoned connoisseurs. Items featured in the e-commerce shop include dried flower, pre-rolls, tinctures, capsules and accessories; and offerings will expand as new product categories, such as edibles and topicals, enter the regulated market in October. To enjoy expedited cannabis delivery, customers simply need to purchase their desired products on kiaro.com, then select “Pineapple Express” as the delivery option.
Pineapple Express Delivery boasts more than a decade of experience in on-demand shipment across multiple industries, and recently expanded into the recreational cannabis space. The company’s comprehensive service includes live GPS tracking, so customers know exactly when to expect their goods. Deliveries are executed under strict security and shipment protocols, and comply with provincial and federal industry regulations.
“Providing our customers with the option of expedited delivery marks a significant milestone in Kiaro’s history, one that we hope will contribute to the normalization of cannabis consumption,” said Daniel Petrov, CEO, Kiaro. “As we continue to expand our footprint across Canada, our goal is to enhance life enjoyment for a greater number of clients, and expedited delivery of our products is an important step to achieving that goal.”
“We are delighted to partner with Kiaro and support the company’s ongoing mission to legitimize the cannabis industry through convenient and inviting retail experiences,” said Randy Rolph, CEO, Pineapple Express. “Kiaro has earned a well-deserved reputation for providing exceptional customer service, and we hope to exceed expectations even further by enabling expedited delivery of their cannabis products.”
Kiaro currently owns two brick-and-mortar locations in Saskatchewan (Saskatoon and La Ronge), both of which are supported by the company’s e-commerce platform. For more information, and to experience the partnership with Pineapple Express Delivery, visit kiaro.com.
SOURCE Kiaro
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan4 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf5 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis4 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care